What progestin‑only contraceptive options are appropriate for a healthy 40‑year‑old woman without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progestin-Only Contraceptive Options for a Healthy 40-Year-Old Woman

For a healthy 40-year-old woman without contraindications, all progestin-only contraceptive methods are appropriate options, with levonorgestrel or copper IUDs being the most highly effective choices, followed by the etonogestrel implant, depot medroxyprogesterone acetate (DMPA) injections, and progestin-only pills. 1

Highly Effective Long-Acting Reversible Contraceptives (LARCs)

Intrauterine Devices (IUDs)

  • Levonorgestrel IUD: Failure rate <1% per year, safe for all women including those over 40, and may decrease menstrual bleeding 1
  • Copper IUD: Failure rate <1% per year, hormone-free alternative that is safe for all women, though it may increase menstrual bleeding and cramping for several months after insertion 1
  • Both IUD types are Category 1 (no restrictions) for women aged ≥20 years and are the most effective contraceptive options available 1

Progestin Implant (Etonogestrel)

  • Failure rate <1% per year, making it highly effective 1
  • Safe for use in midlife women and provides continuous contraception for up to 3 years 2
  • The American College of Rheumatology guidelines note limited data on the newer etonogestrel implant but suggest it is likely safe 1

Moderately Effective Options

Depot Medroxyprogesterone Acetate (DMPA)

  • Injectable contraceptive given every 12 weeks with a failure rate of 5-8% 1
  • Safe for healthy women over 40 without specific contraindications 1
  • Important caveat: Should be avoided in women at risk for osteoporosis, which becomes more relevant in the perimenopausal age group 1

Progestin-Only Pills (POPs)

  • Traditional POPs (norethindrone/norgestrel): Failure rate 5-8%, require strict daily timing (same time every day) for optimal efficacy 1, 3
  • Drospirenone POP: A newer-generation progestin-only pill containing 4mg drospirenone with 24 active days followed by 4 placebo days, offering improved ovulation inhibition and a wider "safety window" for missed pills compared to traditional POPs 4, 3
  • POPs have better contraceptive efficacy in women over 40 due to reduced fertility compared to younger women 5
  • Most common side effect across all POPs is unpredictable bleeding patterns 3, 5

Key Considerations for This Age Group

Advantages in Midlife Women

  • Progestin-only methods are not associated with increased cardiovascular risk, making them particularly safe for women over 40 2
  • These methods can be used safely until menopause without medical contraindications 2
  • Reduced fertility in this age group means even moderately effective methods like POPs perform better than in younger women 5

Practical Guidance

  • If seeking maximum efficacy: Choose an IUD (levonorgestrel or copper) or the etonogestrel implant 1
  • If preferring oral contraception: The drospirenone POP offers better ovulation inhibition and more flexible timing than traditional POPs 4
  • If concerned about bleeding patterns: The levonorgestrel IUD typically decreases menstrual bleeding, while copper IUDs may increase it 1
  • If at risk for osteoporosis: Avoid DMPA and consider IUDs, implant, or POPs instead 1

Common Pitfalls to Avoid

  • Do not assume age 40 is a contraindication to any progestin-only method—all are safe for healthy women in this age group 1, 2
  • Do not overlook counseling about irregular bleeding patterns with POPs, as this is the most common reason for discontinuation 3
  • Do not prescribe DMPA without assessing osteoporosis risk factors, which increase with age 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contraception for midlife women: a review.

Menopause (New York, N.Y.), 2018

Research

Oral contraception over the age of 40.

Annals of the New York Academy of Sciences, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.